18.08.2016
- A wholly owned US subsidiary of India’s Piramal Enterprises has agreed to buy Contract Development and Manufacturing Organization (CDMO) Ash Stevens for nearly $53 million. The...
13.06.2016
- Since the beginning of the 21st century, pharma M&A activity has exploded. Mergers and acquisitions, layoffs, and outsourcing of research and manufacturing have become common place...
20.11.2015
- Piramal Healthcare UK Ltd., a subsidiary of the Indian Piramal group, is spending £2 million to expand its manufacturing base for antibody drug conjugates at Grangemouth, Scotland...
20.10.2014
- Aesica announced the appointment of two senior business development positions. Detlef Behrens has been appointed to the role of Vice President, Business Development, Finished Dose...
13.02.2013
- Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to...
24.10.2012
- Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK, whereby the two parties will offer the seamless contract...
16.05.2012
- Indian drugmaker Piramal Healthcare has agreed to buy a U.S.-based healthcare data provider for $635 million to boost research and development, the company said on Wednesday, a...
16.04.2012
- Indian drugmaker Piramal Healthcare sees revenue potential of $1.5 billion from its new florbetaben molecule, a possible Alzheimer's treatment acquired by the company in a deal...
